Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis

Tohoku Journal of Experimental Medicine

Volumn 223, Issue 3, 2011, Pages 211-214

  Shimizu, Yuko ^a   Fujihara, Kazuo ^a   Kubo, Sachiko ^a   Takahashi, Toshiyuki ^b   Misu, Tatsuro ^a   Nakashima, Ichiro ^a   Yokoyama, Kazumasa ^c   Itoyama, Yasuto ^d   Uchiyama, Shinichiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Yonezawa National Hospital   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Aquaporin 4 antibody; Interferon beta therapy; Neuromyelitis optica; Oligoclonal IgG band; Optic spinal multiple sclerosis

Indexed keywords

AZATHIOPRINE; INTERFERON BETA SERINE; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EMBRYO; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; HUMAN CELL; IMMUNOADSORPTION; JAPANESE; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC SPINAL MULTIPLE SCLEROSIS; PLASMAPHERESIS; RECURRENCE RISK; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; FEMALE; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; RECURRENCE; RETROSPECTIVE STUDIES; SPINAL DISEASES; TREATMENT OUTCOME;

EID: 79952404312     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.223.211     Document Type: Article

References (15)

1. Kira, J. (2003) Multiple sclerosis in the Japanese population. Lancet Neurol., 2, 117-127.
2. McDonald, W.I., Compson, A., Edan, G., Goodkin, D., Hartung, H.P., Lublin, F.D., McFarland, H.F., Paty, D.W., Polman, C.H., Reingold, S.C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van den Noort, Weinshenker, B.G. & Wolinsky, J.S. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on diagnosis of multiple sclerosis. Ann. Neurol., 50, 121-127.
3. Nakashima, I., Fujihara, K., Miyazawa, I., Misu, T., Narikawa, K., Nakamura, M., Watanabe, S., Takahashi, T., Nishiyama, S., Shiga, Y., Sato, S., Weinshenker, B.G. & Iyotama, Y. (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J. Neurol. Neurosurg. Psychiatry, 77, 1073-1075.
4. Nakashima, I., Fukazawa, T., Ota, K., Nohara, C., Warabi, Y., Ohashi, T., Miyazawa, I., Fujihara, K. & Itoyama, Y. (2007) Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features. J. Neurol., 254, 488-492.
5. Osoegawa, M., Kira, J., Fukazawa, T., Fujihara, K., Kikuchi, S., Matsui, M., Kohriyama, T., Sobue, G., Yamamura, T., Itoyama, Y., Saida, T., Sakata, K., Ochi, H. & Matsuoka, T. (2009) Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult. Scler., 15, 159-173.
6. Pittock, S.J., Lennon, V.A., Krecke, K., Wingerchuk, D.M., Lucchinetti, C.F. & Weinshenker, B.G. (2006) Brain abnormalities in neuromyelitis optica. Arch. Neurol., 63, 390-396.
7. Polman, C.H., Reingold, S.C., Edan, G., Filippi, M., Hartung, H.P., Kappos, L., Lubin, F.D., Metz, L.M., McFarland, H.F., O'Conner, P.W., Sandberg-Wollheim, M., Thompson, A.J., Weinshenker, B.G. & Wolonsky, J.S. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald criteria''. Ann. Neurol., 58, 840-846.
8. Saida, T., Tashiro, K., Itoyama, Y., Sato, T., Ohashi, Y. & Zhao, Z. (2005) Inerferon Beta-1b Multiple Sclerosis Study Group of Japan. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multi center study. Neurology, 64, 621-630.
9. Shimizu, J., Hatanaka, Y., Hasegawa, M., Iwata, A., Sugimoto, I., Date, H., Goto, J., Shimizu, T., Takatsu, M., Sakurai, Y., Nakase, H., Uesaka, Y., Hashida, H., Hashimoto, K., Komiya, T. & Tsuji, S. (2010) IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology, 75, 1423-1427.
10. Shimizu, Y., Yokoyama, K., Misu, T., Takahashi, T., Fujihara, K., Kikuchi, S., Itoyama, Y. & Iwata, M. (2008) Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J. Neurol., 255, 305-307.
11. Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Ishii, N. & Itoyama, Y. (2006) Establishment of a new sensitive assay for anti-human aqua-porin-4 antibody in neuromyelitis optica. Tohoku J. Exp. Med., 210, 307-313.
12. Tanaka, M., Tanaka, K. & Komori, M. (2009) Interferon-beta (1b) treatment in neuromyelitis optica. Eur. Neurol., 62, 167-170.
13. Uzawa, A., Mori, M., Hayakawa, S., Masuda, S. & Kuwabara, S. (2010) Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur. J. Neurol., 17, 672-676.
14. Wingerchuk, D.M., Lennon, V.A., Pittock, S.J., Lucchinetti, C.F. & Weinshenker, B.G. (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology, 66, 1485-1489.
15. Yong, V.W., Chabot, S., Stuve, O. & Williams, G. (1998) Inter-feron beta in the treatment of multiple sclerosis: mechanisms of action. Neurology, 51, 682-689.